# EMG Modules as a Novel Biomarker of Basal Ganglia Plasticity in Parkinson's Disease

> **NCT02896816** · NA · TERMINATED · sponsor: **Spaulding Rehabilitation Hospital** · enrollment: 17 (actual)

## Conditions studied

- Parkinson

## Interventions

- **OTHER:** Surface EMG, MRI and PET Scan
- **OTHER:** Surface EMG

## Key facts

- **NCT ID:** NCT02896816
- **Lead sponsor:** Spaulding Rehabilitation Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-08
- **Primary completion:** 2021-05-25
- **Final completion:** 2021-05-25
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** No more funding
- **Last updated:** 2021-10-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02896816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02896816, "EMG Modules as a Novel Biomarker of Basal Ganglia Plasticity in Parkinson's Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02896816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*